Document:

Exhibit 10.11

 

 

August 17,
2011

 

Paul Slavin

 

Dear Paul,

 

On behalf of
  Everyday Health Inc. (the “Company”),
I am pleased to offer you the position of Senior Vice President reporting to
  Goli Sheikholeslami. The terms of your employment relationship with the Company
  will be set forth below.

 

Compensation. Your start date will be September 6, 2011.
Your base compensation is annualized at $300,000. Additionally, you will receive a $35,000 sign-on bonus (subject to applicable
tax withholdings) that will be paid within 30 days of your start date. You are an exempt employee and therefore not eligible to
receive overtime pay. Everyday Health employees are paid semi-monthly on the 15th and at the end of the month. You are
eligible for an annual performance bonus with a target of 75% of your base salary. Your bonus is contingent upon meeting individual
and company goals and will be pro-rated for 2011 based on your start date. As an employee of the Company, you will be eligible
for the comprehensive benefits package that we offer to our regular full time employees. Details of this package are enclosed
and will be reviewed with you in your first week of employment.

 

Severance. If the Company terminates your employment
without Cause (as defined below), and other than as a result of your death or disability, and provided such termination constitutes
a “separation from service” (as defined under Treasury Regulation Section 1.409A-1(h)), then subject to your obligations
below, the Company will pay to you, as severance, an amount equal to 6 months of your then-current base salary (the “Severance
Benefits”), less applicable taxes. The Severance Benefits are conditional upon (a) your continuing to comply with your
obligations under your Agreement to Protect Information. Assign Inventions and Prevent Unfair Competition and Unfair Solicitation
(the “Confidentiality Agreement”) during the period of time in which you are receiving the Severance Benefits
and (b) your delivering to the Company an effective, general release of claims in favor of the Company in a form reasonably acceptable
to the Company within 30 days following your termination date. The Severance Benefits will be paid as salary continuation on the
Company’s regular payroll schedule over the 6 month period immediately following your termination date, and will be subject to
applicable tax withholdings: provided, however, that no payments will be made prior to the 30th day following your termination
date. On the 30th day following your termination date, the Company will pay you in a lump sum the Severance Benefits that you
would have received on or prior to such date under the original schedule but for the delay while waiting for the effectiveness
of the release with the balance of the Severance Benefits being paid as originally scheduled.

 

For purposes of this Agreement, “Cause”
means (A) your conviction (including a guilty plea or a no contest plea) of a felony, or of any other crime involving fraud,
dishonesty or moral turpitude; (B) your attempted commission of or participation in a fraud or act of material dishonesty
against the Company; (C) your material breach of any written agreement between you and the Company (including but not limited
to your Confidentiality Agreement) or material breach or neglect of any statutory or fiduciary duty you owe to the Company;
or (D) your conduct that constitutes gross insubordination, incompetence or habitual neglect of your duties

 

It is intended that all of the Severance Benefits payable under
this letter satisfy, to the greatest extent possible, the exemptions from the application of Code Section 409A provided under Treasury
Regulations 1.409A-1(b)(4) and 1.409A-1(b)(9), and this letter will be construed to the

 

345 Hudson Street
16TH Floor | New York, NY 10014 | Phone (646) 728-9500 | Fax (646) 728-9501

    	 

    	

    

greatest extent possible as consistent with those provisions.
For purposes of Code Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)),
your right to receive any installment payments under this letter (whether severance payments, reimbursements or otherwise) shall
be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all
times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this letter, if you are deemed
by the Company at the time of your separation from service to be a “specified employee” for purposes of Code Section
409A(a)(2)(B)(i), and if any of the payments upon separation from service set forth herein are deemed to be “deferred compensation”,
then to the extent delayed commencement of any portion of such payments is required in order to avoid a prohibited distribution
under Code Section 409A(a)(2)(B)(i) and the related adverse taxation under Section 409A, such payments shall not be provided to
you prior to the earliest of (i) the expiration of the six-month period measured from the date of your Separation from Service
with the Company, (ii) the date of your death or (iii) such earlier date as permitted under Section 409A without the imposition
of adverse taxation. Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period,
all payments deferred pursuant to this paragraph shall be paid in a lump sum to you, and any remaining payments due shall be paid
as otherwise provided herein.

 

Equity. You will receive a stock option grant of 125,000
common shares. The first 25% of these options vest on your first anniversary of employment and the balance vests monthly thereafter
over the next 36 months. The Company’s board of directors will determine the strike price of all options at the end of each calendar
quarter following the grant date in accordance with its past practice. In addition, this initial option grant will provide that
if you remain in continuous service with the Company at the time of a “change in control” (as defined in the applicable
stock plan), to the extent then outstanding, this initial grant will become vested and exercisable as of immediately prior to
the closing of such transaction as to 50% of the then-unvested option shares subject to this initial grant. In addition, you will
be eligible for future option grants at the discretion of the management and the Board. The stock option grant will be subject
to the applicable plan, provided, that, upon the termination of your employment by the Company other than for Cause, you shall
have a period of one year to exercise the vested stock options.

 

Paid Time Off: You will be eligible for all National
Holidays identified by the Company. In addition, full-time, salaried employees do not have a fixed or capped amount of paid time
off. Eligible employees may take time off from work at their discretion, with manager approval, so long as their absences are
not excessive and do not interfere with their ability to satisfy the requirements of their position.

 

Non-Disclosure and Developments Agreement. Like all Company
employees, you will be required to sign the Company’s standard “Agreement to Protect Information, Assign Inventions, and
Prevent Unfair Competition and Unfair Solicitation” as a condition of employment. In addition, you will be required to
abide by the Company’s strict policy that prohibits any new employee from using or bringing with him or her from any previous
employer any confidential information, trade secrets, or proprietary materials or processes of such former employer.

 

At-Will Employment. This letter does not constitute a
guarantee of employment or an employment contract for any specified period of time. You will be an employee-at-will, meaning that
either you or the Company may terminate your employment relationship at any time, without notice, for any reason or no reason

 

Federal Immigration Law. For purposes of federal immigration
law, you are required to provide to the Company documentary evidence of your identity and eligibility for employment in the United
States. Documentation must be provided to us within three (3) business days of your commencement date, or our employment relationship
with you may be terminated.

    	 

    	

    

We are pleased that you are joining our team to work with us
to help the Company reach its full potential. Please confirm your acceptance of this offer by signing and returning one copy of
this letter. If you have any questions, please feel free to contact our Human Resources Analyst. Patricia Nowack at (646) 728-9687.

 

Sincerely,

 

/s/ Deborah Josephs

Deborah Josephs

SVP Human Resources

 

Cc: Goli Sheikholeslami

 

The foregoing terms and conditions are hereby accepted:

 

	Employee Signature:	/s/ Paul Slavin	 
	 	 	 
	Print Name:	Paul Slavin	 
	 	 	 
	Date:	9/7/11Exhibit 10.11.1

 

February 25, 2013

 

Paul Slavin
325 West End Ave, Apt 1a
New York, NY 10023

 

Dear Paul:

 

Upon your hiring by Everyday Health, Inc. (the “Company”)
in 2011, you and the Company executed the attached employment letter dated August 17, 2011(“Employment Letter”). In
connection with your promotion to Chief Operating Officer of the Company, you and the Company would like to amend some of the
terms and conditions contained in the Employment Letter as set forth below:

 

Compensation. Effective
February 7, 2013, your base salary will be $350,000 on an annualized basis. Beginning with the 2013 calendar year, you will
be eligible for an annual performance bonus with a target of 100% of your base salary. The metrics and targets that determine
the basis for achievement and payout of the performance bonus are designated by the Company’s Compensation Committee on
an annual basis. With respect to calendar year 2013 only, in addition to the performance bonus referenced above, in the event
that – and only if - the Company achieves the internal adjusted EBITDA forecast for the overall Company, you shall be paid
$200,000 at the same time that the performance bonus payments are made to Company employees; provided, however, in the event
of a “change of control” (as defined in the applicable stock plan) prior to December 31, 2013, you shall be paid
the $200,000 in a lump sum within ten business days of the closing of the change of control transaction. As you know, the
internal adjusted EBITDA forecast is currently in the process of being finalized.

 

Severance: The severance period
of six months referenced in the Employment Letter will be increased to 12 months. In addition, you will receive 12 months’
severance if you resign from employment with the Company for “Good Reason” within ten (10) days after the occurrence
of one of the events specified in the definition of Good Reason, by giving notice that you intend to terminate your employment
for Good Reason on the thirtieth (30) day following the Company’s receipt of your notice, if the Company has not cured the
event that gives rise to Good Reason before the end of such thirty (30) day period. “Good Reason” for
resignation shall mean the occurrence of any of the following without the your prior written consent: (i) the assignment to you
of any duties or responsibilities which result in the material diminution of your then current position (including in the event
that you no longer report to the Chief Executive Officer of the Company; provided, however, that no longer reporting to the Chief
Executive Officer following a “change of control” (as defined in the applicable stock plan) of the Company shall
not constitute, in and of itself, a material diminution of your then current position); (ii) a reduction by the Company in your
base salary or target bonus; or (iii) relocation of your principal place of business more than fifty (50) miles from its current
location.

 

Equity. You will receive two separate option grants.
(1) Contingent on your forfeiture of the outstanding option grant which was granted to you in 2011 (totaling 100,000 options
at an $8 strike price), you will receive a second option grant of 100,000 common shares. With respect to

    	 

    	

    

this second option grant, 37,500 options shall be immediately
exercisable and the remaining 62,500 options shall vest monthly over a 30 month period beginning on March 1, 2013. The exercise
price for this option grant will be $6.05, the current fair market value of the Company’s common stock. (2) You will also
receive a stock option grant of 275,000 common shares, which will be formally granted at the same time as the Compensation Committee
approves option grants to other senior executive officers (expected to be in April) and the Board of Directors or Compensation
Committee shall determine the strike price for this option grant, consistent with its past practice. Fifty percent of these options
shall have time-based vesting, and the Compensation Committee shall have the authority to link the vesting of up to fifty percent
of these options to the performance of the Company (e.g. achievement of an adjusted EBITDA target). The Compensation Committee
is currently in the process of determining the performance metrics to use with respect to the senior executive grants. With respect
to the options that are time-based, the first 25% of the time-based options will vest on March 1, 2014 and the balance will vest
monthly thereafter over the next 36 months. Both option grants will provide that if you remain in continuous service with the
Company at the time of a “change of control” as defined in the applicable stock plan), to the extent then outstanding,
the grant will become vested and exercisable as of immediately prior to the closing of such transaction as to 50% of the then-unvested
option shares. Both stock option grants will provide that, upon termination of your employment by the Company other than for Cause
(as defined in the Employment Letter), you shall have a period of one year to exercise the vested stock options.

 

In addition to the above two option grants, you will
receive a third stock option grant of 50,000 common shares in the first quarter of 2014 in the event that – and only if - the
Company achieves the Board-approved (as opposed to the internal targets referenced above in the Compensation section)
adjusted EBITDA forecast for the overall Company. In the event this option grant is made, (i) the Compensation Committee will
determine whether the vesting of this option grant is time-based or performance-based, or a mix of both; (ii) the
Company’s Board of Directors or Compensation Committee shall determine the strike price for the option grant at the
time of grant, consistent with its past practice; (iii) the option grant will provide that if you remain in continuous
service with the Company at the time of a “change of control” as defined in the applicable stock plan), to the
extent then outstanding, the grant will become vested and exercisable as of immediately prior to the closing of such
transaction as to 50% of the then-unvested option shares; and (iv) the stock option grant will provide that, upon termination
of your employment by the Company other than for Cause (as defined in the Employment Letter), you shall have a period of one
year to exercise the vested stock options.

 

Business Expenses. All approved business expenses will
be reimbursed, following submission of an approved expense report. In addition, you shall be reimbursed for the actual cost of
a parking spot nearby the Company’s headquarters (up to a maximum amount of $500 per month).

 

Except as specifically addressed in this letter, all the terms
and conditions contained in the Employment Letter shall remain in full force and effect. Please confirm your acceptance of the
Employment Letter, as modified by this letter by returning a signed copy of this letter.

 

Sincerely,

/s/ Ben Wolin

Ben Wolin

Chief Executive Officer

    	2

    	

    

The foregoing terms and conditions are hereby accepted:

 

	Employee Signature: 	/s/ Paul Slavin	 
	 	 	 
	Print Name:	Paul Slavin	 
	 	 	 
	Date:	February 25, 2013	 

    	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]